Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 3/20 | 0.56 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.55 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.55 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.55 |
| ▸ | CALCRL | Q16602 | 2/20 | 0.54 |
| ▸ | CALCR | P30988 | 3/20 | 0.52 |
| ▸ | TFPI | P10646 | 2/20 | 0.52 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30560036 | 0.89 | OPRD1 (0.60) | OPRM1OPRD1 | |
| SCHEMBL29658853 | 0.88 | CALCRL (0.59) | OPRD1CALCRLIL23R | |
| SCHEMBL31688352 | 0.88 | OPRD1 (0.60) | KEAP1OPRM1OPRD1OPRK1 | |
| SCHEMBL31745620 | 0.88 | KDM1A (0.58) | KEAP1TFPI | |
| SCHEMBL30607393 | 0.87 | CALCRL (0.59) | KEAP1OPRM1OPRD1OPRK1CALCRL | |
| SCHEMBL31745538 | 0.87 | KEAP1 (0.57) | KEAP1CALCRLCALCRTFPI | |
| SCHEMBL31688332 | 0.86 | OPRM1 (0.61) | KEAP1OPRM1OPRD1OPRK1CALCR | |
| SCHEMBL31683251 | 0.86 | OPRD1 (0.60) | KEAP1OPRM1OPRD1OPRK1CALCR | |
| SCHEMBL29438379 | 0.85 | NPY2R (0.58) | CALCRTFPI | |
| SCHEMBL29352561 | 0.85 | KEAP1 (0.64) | KEAP1OPRM1OPRD1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120623280-A | Bone destruction resistant bioactive polypeptide targeting osteoclast membrane surface receptor and application thereof | 广西师范大学 | 2025-09-12 | — | — | CN | disclosed |